Czech National Bank Has $9.02 Million Holdings in Kenvue Inc. (NYSE:KVUE)

Czech National Bank grew its holdings in Kenvue Inc. (NYSE:KVUE) by 6.9% during the third quarter, Holdings Channel.com reports. The firm owned 390,139 shares of the company’s stock after acquiring an additional 25,253 shares during the quarter. Czech National Bank’s holdings in Kenvue were worth $9,024,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. The Manufacturers Life Insurance Company grew its stake in shares of Kenvue by 2.6% in the fourth quarter. The Manufacturers Life Insurance Company now owns 1,598,567 shares of the company’s stock valued at $34,417,000 after buying an additional 40,995 shares in the last quarter. Rafferty Asset Management LLC grew its stake in shares of Kenvue by 4.2% in the fourth quarter. Rafferty Asset Management LLC now owns 133,737 shares of the company’s stock valued at $2,879,000 after buying an additional 5,353 shares in the last quarter. Tower Research Capital LLC TRC grew its stake in shares of Kenvue by 131.6% in the fourth quarter. Tower Research Capital LLC TRC now owns 217,249 shares of the company’s stock valued at $4,677,000 after buying an additional 123,460 shares in the last quarter. Cetera Advisor Networks LLC grew its stake in shares of Kenvue by 85.1% in the fourth quarter. Cetera Advisor Networks LLC now owns 176,513 shares of the company’s stock valued at $3,800,000 after buying an additional 81,144 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado bought a new position in shares of Kenvue in the fourth quarter valued at $5,330,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

KVUE has been the subject of several analyst reports. Jefferies Financial Group started coverage on shares of Kenvue in a research note on Tuesday, September 24th. They issued a “buy” rating and a $27.00 target price for the company. JPMorgan Chase & Co. lifted their price objective on shares of Kenvue from $22.00 to $24.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Piper Sandler lifted their price objective on shares of Kenvue from $20.00 to $21.00 and gave the stock a “neutral” rating in a research report on Monday, September 23rd. Royal Bank of Canada cut shares of Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.00 price objective for the company. in a research report on Tuesday, September 24th. Finally, UBS Group lifted their price objective on shares of Kenvue from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Kenvue presently has a consensus rating of “Hold” and an average price target of $22.10.

Kenvue Stock Performance

Shares of KVUE traded down $0.11 during midday trading on Friday, reaching $22.16. 8,451,647 shares of the stock were exchanged, compared to its average volume of 18,410,244. Kenvue Inc. has a twelve month low of $17.67 and a twelve month high of $23.55. The company has a quick ratio of 0.68, a current ratio of 0.99 and a debt-to-equity ratio of 0.69. The company has a market cap of $42.43 billion, a P/E ratio of 28.41, a PEG ratio of 2.92 and a beta of 1.40. The stock’s 50 day simple moving average is $21.84 and its 200 day simple moving average is $20.16.

Kenvue (NYSE:KVUE) last posted its earnings results on Tuesday, August 6th. The company reported $0.32 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.04. Kenvue had a return on equity of 21.80% and a net margin of 7.23%. The company had revenue of $4 billion during the quarter, compared to the consensus estimate of $3.93 billion. During the same quarter last year, the firm earned $0.32 earnings per share. The company’s revenue was down .3% on a year-over-year basis. On average, sell-side analysts expect that Kenvue Inc. will post 1.08 earnings per share for the current year.

Kenvue Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, August 28th. Investors of record on Wednesday, August 14th were paid a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a yield of 3.70%. The ex-dividend date was Wednesday, August 14th. This is an increase from Kenvue’s previous quarterly dividend of $0.20. Kenvue’s payout ratio is 105.13%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.